These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2567529)

  • 41. [Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis].
    Henriksen JH; Fuglsang S; Bendtsen F; Christensen E; Møller S
    Ugeskr Laeger; 2004 Aug; 166(35):2995-8. PubMed ID: 15387011
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of esmolol in patient with portal hypertension].
    Figueroa Yusta J; Gilsanz F; De Dios Tomás E
    Rev Esp Anestesiol Reanim; 2001; 48(7):349. PubMed ID: 11591288
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of ondansetron on portal hemodynamics in liver cirrhosis.
    Tripkovic M; Kozjek F; Krizman I; Jereb J; Francetic I; Grabnar I; Mrhar A
    Int J Clin Pharmacol Ther; 2000 Sep; 38(9):436-40. PubMed ID: 11020031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemorrhage caused by rupture of gastroesophageal varices: should we dilate the liver or strangulate the varices?].
    Calès P
    Gastroenterol Clin Biol; 1995 Nov; 19(11):899-902. PubMed ID: 8746048
    [No Abstract]   [Full Text] [Related]  

  • 45. Portal-systemic encephalopathy and gastrointestinal bleeding after cardioselective beta-blocker (metoprolol) administration to patients with portal hypertension.
    Uribe M; Orozco H; Morán S; Guevara L; Poo JL; Vargas-Vorackova F
    Arch Med Res; 1995; 26(3):221-6. PubMed ID: 8580671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Propranolol or sclerotherapy to prevent variceal rebleeding.
    Dwivedi M; Misra SP
    Natl Med J India; 1995; 8(5):222. PubMed ID: 7549854
    [No Abstract]   [Full Text] [Related]  

  • 48. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
    Gitlin N
    Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacological treatment of the portal hypertension].
    Castañeda Romero B
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacological treatment of portal hypertension: present and future.
    Lebrec D
    J Hepatol; 1998 May; 28(5):896-907. PubMed ID: 9625326
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status and future goals of the pharmacologic reduction of portal hypertension.
    Lebrec D
    Am J Surg; 1990 Jul; 160(1):19-25. PubMed ID: 1973334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-receptor blocking treatment in portal hypertension.
    Olsson R
    Scand J Gastroenterol; 1990 Jul; 25(7):641-6. PubMed ID: 1975704
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.
    Groszmann RJ
    Gastroenterology; 1997 Nov; 113(5):1794-7. PubMed ID: 9352888
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of beta-receptor blockaders in hypertrophic obstructive cardiomyopathy (HOCM)].
    Kuhn H; Loogen F
    Internist (Berl); 1978 Sep; 19(9):527-31. PubMed ID: 29851
    [No Abstract]   [Full Text] [Related]  

  • 56. The propranolol therapy in cirrhotic patients.
    Efe C; Purnak T; Ozaslan E; Sahin M; Astan R
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1203; author reply 1204-5. PubMed ID: 21039680
    [No Abstract]   [Full Text] [Related]  

  • 57. "A la carte" treatment of portal hypertension or just "hors d'oeuvres".
    Blendis L; Lurie Y; Oren R
    Gastroenterology; 2003 Jun; 124(7):1993-5. PubMed ID: 12806642
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacologic treatment of portal hypertension].
    Bosch J
    An Med Interna; 1991 Jun; 8 Suppl 2():4-7. PubMed ID: 1678971
    [No Abstract]   [Full Text] [Related]  

  • 59. [Efficacy in the use of beta-adrenergic blockaders in the treatment of thyrotoxic disorders of the heart].
    Smolenskiĭ VS; Rom-Boguslavskaia ES; Abinder AA; Levchenko TP
    Probl Endokrinol (Mosk); 1973; 19(6):20-5. PubMed ID: 4148862
    [No Abstract]   [Full Text] [Related]  

  • 60. Blocking the bleeding way.
    Blendis L; Wong F
    Gastroenterology; 1998 Jul; 115(1):230-2. PubMed ID: 9649483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.